[#item_full_content] A second group of medical cannabis businesses are suing the Drug Enforcement Administration (DEA) over restrictions the agency is placing on marijuana businesses in conjunction with the Trump administration’s federal rescheduling move that industry observers and regulators believe could upend state-licensed markets. The latest challenge comes from four vertically integrated medical cannabis companies that say the
Read More